date
Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.453826488134824.
The log-likelihood improved by 3.404.
Iteration 2 of at most 500:
Optimizing with step length 0.78289378756119.
The log-likelihood improved by 2.863.
Iteration 3 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.5011.
Step length converged once. Increasing MCMC sample size.
Iteration 4 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.5376.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree0  degree1  degree2  degree3  degree4  degree5  degree6  degree7 
       4       18     1260      998      802      353      390      344 
 degree8  degree9 degree10 degree11 degree12 degree13 degree14 degree15 
     303      215      126       93       52       24        8        7 
degree16 degree17 degree19 
       1        1        1 
1 
disease_progression 
H-positive risk:  830 907 138 914 408 127 846 452 128 67 132 51 
H-negative risk:  907 830 846 914 452 408 127 138 132 128 51 67 
New BC onsets:  3
BC status:  4997 3 
BC subtype:  4997 2 1 

clinical_engagement 
diagnosis 
demography 
68 new agents 
2 
disease_progression 
H-positive risk:  836 917 140 914 403 128 847 443 124 66 129 53 
H-negative risk:  917 836 847 914 443 403 128 140 129 124 53 66 
New BC onsets:  5
BC status:  4995 5 
BC subtype:  4995 3 2 

clinical_engagement 
diagnosis 
demography 
64 new agents 
3 
disease_progression 
H-positive risk:  837 921 139 911 404 130 849 438 122 65 131 53 
H-negative risk:  921 837 849 911 438 404 130 139 131 122 53 65 
New BC onsets:  7
BC status:  4993 7 
BC subtype:  4993 5 2 

clinical_engagement 
diagnosis 
demography 
50 new agents 
4 
disease_progression 
H-positive risk:  843 915 140 913 396 130 853 437 123 64 132 54 
H-negative risk:  915 843 853 913 437 396 130 140 132 123 54 64 
New BC onsets:  10
BC status:  4990 10 
BC subtype:  4990 8 2 

clinical_engagement 
diagnosis 
demography 
58 new agents 
5 
disease_progression 
H-positive risk:  850 922 141 908 391 130 859 430 122 65 129 53 
H-negative risk:  922 850 859 908 430 391 130 141 129 122 53 65 
New BC onsets:  13
BC status:  4987 13 
BC subtype:  4987 11 2 

clinical_engagement 
diagnosis 
demography 
53 new agents 
6 
disease_progression 
H-positive risk:  850 925 142 912 390 131 857 423 123 65 129 53 
H-negative risk:  925 850 857 912 423 390 131 142 129 123 53 65 
New BC onsets:  14
BC status:  4986 14 
BC subtype:  4986 12 2 

clinical_engagement 
diagnosis 
demography 
59 new agents 
7 
disease_progression 
H-positive risk:  860 925 144 911 386 131 860 413 124 61 133 52 
H-negative risk:  925 860 860 911 413 386 131 144 133 124 52 61 
New BC onsets:  18
BC status:  4982 18 
BC subtype:  4982 16 2 

clinical_engagement 
diagnosis 
demography 
74 new agents 
8 
disease_progression 
H-positive risk:  862 931 146 905 388 131 861 407 123 61 132 53 
H-negative risk:  931 862 861 905 407 388 131 146 132 123 53 61 
New BC onsets:  19
BC status:  4981 19 
BC subtype:  4981 17 2 

clinical_engagement 
diagnosis 
demography 
58 new agents 
9 
disease_progression 
H-positive risk:  868 939 145 899 387 135 857 401 121 61 134 53 
H-negative risk:  939 868 857 899 401 387 135 145 134 121 53 61 
New BC onsets:  21
BC status:  4979 21 
BC subtype:  4979 19 2 

clinical_engagement 
diagnosis 
demography 
61 new agents 
10 
disease_progression 
H-positive risk:  876 939 144 899 382 136 854 401 121 62 136 50 
H-negative risk:  939 876 854 899 401 382 136 144 136 121 50 62 
New BC onsets:  23
BC status:  4977 23 
BC subtype:  4977 20 3 

clinical_engagement 
diagnosis 
demography 
58 new agents 
11 
disease_progression 
H-positive risk:  878 944 144 904 381 135 855 394 120 62 133 50 
H-negative risk:  944 878 855 904 394 381 135 144 133 120 50 62 
New BC onsets:  24
BC status:  4976 24 
BC subtype:  4976 21 3 

clinical_engagement 
diagnosis 
demography 
72 new agents 
12 
disease_progression 
H-positive risk:  883 949 145 902 382 136 850 390 120 62 133 48 
H-negative risk:  949 883 850 902 390 382 136 145 133 120 48 62 
New BC onsets:  25
BC status:  4975 25 
BC subtype:  4975 21 4 

clinical_engagement 
diagnosis 
demography 
56 new agents 
13 
disease_progression 
H-positive risk:  818 855 129 998 381 125 923 384 131 60 148 48 
H-negative risk:  855 818 923 998 384 381 125 129 148 131 48 60 
New BC onsets:  28
BC status:  4972 28 
BC subtype:  4972 23 5 

clinical_engagement 
diagnosis 
demography 
233 new agents 
14 
disease_progression 
H-positive risk:  861 877 136 935 412 127 878 398 122 65 143 46 
H-negative risk:  877 861 878 935 398 412 127 136 143 122 46 65 
New BC onsets:  32
BC status:  4968 32 
BC subtype:  4968 22 10 

clinical_engagement 
diagnosis 
demography 
45 new agents 
15 
disease_progression 
H-positive risk:  857 881 134 935 412 128 881 393 124 66 142 47 
H-negative risk:  881 857 881 935 393 412 128 134 142 124 47 66 
New BC onsets:  35
BC status:  4965 35 
BC subtype:  4965 25 10 

clinical_engagement 
diagnosis 
demography 
67 new agents 
16 
disease_progression 
H-positive risk:  860 885 134 936 413 126 878 390 124 65 143 46 
H-negative risk:  885 860 878 936 390 413 126 134 143 124 46 65 
New BC onsets:  36
BC status:  4964 36 
BC subtype:  4964 26 10 

clinical_engagement 
diagnosis 
demography 
62 new agents 
17 
disease_progression 
H-positive risk:  869 887 130 924 412 127 881 393 122 68 143 44 
H-negative risk:  887 869 881 924 393 412 127 130 143 122 44 68 
New BC onsets:  38
BC status:  4962 38 
BC subtype:  4962 28 10 

clinical_engagement 
diagnosis 
demography 
63 new agents 
18 
disease_progression 
H-positive risk:  871 890 130 926 409 128 880 389 122 68 143 44 
H-negative risk:  890 871 880 926 389 409 128 130 143 122 44 68 
New BC onsets:  38
BC status:  4962 38 
BC subtype:  4962 28 10 

clinical_engagement 
diagnosis 
demography 
69 new agents 
19 
disease_progression 
H-positive risk:  878 892 130 929 403 128 877 387 121 66 144 45 
H-negative risk:  892 878 877 929 387 403 128 130 144 121 45 66 
New BC onsets:  39
BC status:  4961 39 
BC subtype:  4961 29 10 

clinical_engagement 
diagnosis 
demography 
74 new agents 
20 
disease_progression 
H-positive risk:  883 893 132 934 403 129 868 383 124 63 143 45 
H-negative risk:  893 883 868 934 383 403 129 132 143 124 45 63 
New BC onsets:  39
BC status:  4961 39 
BC subtype:  4961 28 11 

clinical_engagement 
diagnosis 
demography 
72 new agents 
21 
disease_progression 
H-positive risk:  887 898 135 928 396 129 870 377 124 64 145 47 
H-negative risk:  898 887 870 928 377 396 129 135 145 124 47 64 
New BC onsets:  45
BC status:  4955 45 
BC subtype:  4955 32 13 

clinical_engagement 
diagnosis 
demography 
73 new agents 
22 
disease_progression 
H-positive risk:  884 903 136 925 389 132 876 377 125 63 143 47 
H-negative risk:  903 884 876 925 377 389 132 136 143 125 47 63 
New BC onsets:  46
BC status:  4954 46 
BC subtype:  4954 33 13 

clinical_engagement 
diagnosis 
demography 
65 new agents 
23 
disease_progression 
H-positive risk:  891 906 137 926 383 131 883 367 125 63 142 46 
H-negative risk:  906 891 883 926 367 383 131 137 142 125 46 63 
New BC onsets:  47
BC status:  4953 47 
BC subtype:  4953 34 13 

clinical_engagement 
diagnosis 
demography 
67 new agents 
24 
disease_progression 
H-positive risk:  895 907 139 924 383 132 878 364 127 62 143 46 
H-negative risk:  907 895 878 924 364 383 132 139 143 127 46 62 
New BC onsets:  49
BC status:  4951 49 
BC subtype:  4951 36 13 

clinical_engagement 
diagnosis 
demography 
60 new agents 
25 
disease_progression 
H-positive risk:  821 843 133 989 380 129 955 363 128 62 152 45 
H-negative risk:  843 821 955 989 363 380 129 133 152 128 45 62 
New BC onsets:  58
BC status:  4942 58 
BC subtype:  4942 38 20 

clinical_engagement 
diagnosis 
demography 
171 new agents 
26 
disease_progression 
H-positive risk:  834 870 138 944 402 135 917 387 125 61 141 46 
H-negative risk:  870 834 917 944 387 402 135 138 141 125 46 61 
New BC onsets:  63
BC status:  4937 63 
BC subtype:  4937 43 20 

clinical_engagement 
diagnosis 
demography 
57 new agents 
27 
disease_progression 
H-positive risk:  836 874 135 948 392 138 925 388 124 57 138 45 
H-negative risk:  874 836 925 948 388 392 138 135 138 124 45 57 
New BC onsets:  64
BC status:  4936 64 
BC subtype:  4936 44 20 

clinical_engagement 
diagnosis 
demography 
68 new agents 
28 
disease_progression 
H-positive risk:  842 875 137 940 397 138 928 380 127 55 136 45 
H-negative risk:  875 842 928 940 380 397 138 137 136 127 45 55 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 44 21 

clinical_engagement 
diagnosis 
demography 
60 new agents 
29 
disease_progression 
H-positive risk:  845 873 135 939 389 139 923 390 128 55 139 45 
H-negative risk:  873 845 923 939 390 389 139 135 139 128 45 55 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 44 21 

clinical_engagement 
diagnosis 
demography 
66 new agents 
30 
disease_progression 
H-positive risk:  848 881 136 936 391 140 924 388 125 52 136 43 
H-negative risk:  881 848 924 936 388 391 140 136 136 125 43 52 
New BC onsets:  67
BC status:  4933 67 
BC subtype:  4933 44 23 

clinical_engagement 
diagnosis 
demography 
54 new agents 
31 
disease_progression 
H-positive risk:  853 880 137 943 392 139 924 378 123 52 136 43 
H-negative risk:  880 853 924 943 378 392 139 137 136 123 43 52 
New BC onsets:  69
BC status:  4931 69 
BC subtype:  4931 44 25 

clinical_engagement 
diagnosis 
demography 
54 new agents 
32 
disease_progression 
H-positive risk:  867 882 138 943 389 140 917 373 121 51 136 43 
H-negative risk:  882 867 917 943 373 389 140 138 136 121 43 51 
New BC onsets:  68
BC status:  4932 68 
BC subtype:  4932 44 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
33 
disease_progression 
H-positive risk:  872 887 139 944 386 141 915 367 119 51 137 42 
H-negative risk:  887 872 915 944 367 386 141 139 137 119 42 51 
New BC onsets:  67
BC status:  4933 67 
BC subtype:  4933 44 23 

clinical_engagement 
diagnosis 
demography 
67 new agents 
34 
disease_progression 
H-positive risk:  875 892 141 941 374 141 920 371 120 47 138 40 
H-negative risk:  892 875 920 941 371 374 141 141 138 120 40 47 
New BC onsets:  67
BC status:  4933 67 
BC subtype:  4933 43 24 

clinical_engagement 
diagnosis 
demography 
63 new agents 
35 
disease_progression 
H-positive risk:  871 898 141 952 365 140 923 368 119 47 138 38 
H-negative risk:  898 871 923 952 368 365 140 141 138 119 38 47 
New BC onsets:  68
BC status:  4932 68 
BC subtype:  4932 44 24 

clinical_engagement 
diagnosis 
demography 
53 new agents 
36 
disease_progression 
H-positive risk:  872 903 141 951 362 143 922 364 118 47 139 38 
H-negative risk:  903 872 922 951 364 362 143 141 139 118 38 47 
New BC onsets:  68
BC status:  4932 68 
BC subtype:  4932 45 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
37 
disease_progression 
H-positive risk:  810 856 130 1008 351 123 986 366 134 45 152 39 
H-negative risk:  856 810 986 1008 366 351 123 130 152 134 39 45 
New BC onsets:  70
BC status:  4930 70 
BC subtype:  4930 47 23 

clinical_engagement 
diagnosis 
demography 
145 new agents 
38 
disease_progression 
H-positive risk:  821 872 131 980 367 127 946 381 132 51 143 49 
H-negative risk:  872 821 946 980 381 367 127 131 143 132 49 51 
New BC onsets:  72
BC status:  4928 72 
BC subtype:  4928 49 23 

clinical_engagement 
diagnosis 
demography 
83 new agents 
39 
disease_progression 
H-positive risk:  829 875 131 985 362 131 943 381 123 51 139 50 
H-negative risk:  875 829 943 985 381 362 131 131 139 123 50 51 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 49 25 

clinical_engagement 
diagnosis 
demography 
59 new agents 
40 
disease_progression 
H-positive risk:  823 878 131 988 365 131 943 379 122 51 140 49 
H-negative risk:  878 823 943 988 379 365 131 131 140 122 49 51 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 49 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
41 
disease_progression 
H-positive risk:  821 886 131 987 361 130 936 385 122 51 142 48 
H-negative risk:  886 821 936 987 385 361 130 131 142 122 48 51 
New BC onsets:  76
BC status:  4924 76 
BC subtype:  4924 50 26 

clinical_engagement 
diagnosis 
demography 
68 new agents 
42 
disease_progression 
H-positive risk:  833 882 131 986 361 131 935 377 123 52 141 48 
H-negative risk:  882 833 935 986 377 361 131 131 141 123 48 52 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 51 27 

clinical_engagement 
diagnosis 
demography 
65 new agents 
43 
disease_progression 
H-positive risk:  835 883 127 985 359 131 935 379 126 51 141 48 
H-negative risk:  883 835 935 985 379 359 131 127 141 126 48 51 
New BC onsets:  78
BC status:  4922 78 
BC subtype:  4922 51 27 

clinical_engagement 
diagnosis 
demography 
64 new agents 
44 
disease_progression 
H-positive risk:  836 886 129 986 352 132 939 375 127 50 140 48 
H-negative risk:  886 836 939 986 375 352 132 129 140 127 48 50 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 56 28 

clinical_engagement 
diagnosis 
demography 
65 new agents 
45 
disease_progression 
H-positive risk:  836 890 131 983 356 131 941 372 127 49 138 46 
H-negative risk:  890 836 941 983 372 356 131 131 138 127 46 49 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 58 30 

clinical_engagement 
diagnosis 
demography 
62 new agents 
46 
disease_progression 
H-positive risk:  836 891 131 986 352 132 939 372 127 49 140 45 
H-negative risk:  891 836 939 986 372 352 132 131 140 127 45 49 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 58 30 

clinical_engagement 
diagnosis 
demography 
74 new agents 
47 
disease_progression 
H-positive risk:  844 899 129 977 351 132 932 372 128 48 142 46 
H-negative risk:  899 844 932 977 372 351 132 129 142 128 46 48 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 59 31 

clinical_engagement 
diagnosis 
demography 
57 new agents 
48 
disease_progression 
H-positive risk:  845 901 129 984 349 131 925 377 129 47 139 44 
H-negative risk:  901 845 925 984 377 349 131 129 139 129 44 47 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 59 30 

clinical_engagement 
diagnosis 
demography 
70 new agents 
49 
disease_progression 
H-positive risk:  791 866 123 1024 346 119 977 376 143 46 142 47 
H-negative risk:  866 791 977 1024 376 346 119 123 142 143 47 46 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 61 30 

clinical_engagement 
diagnosis 
demography 
137 new agents 
50 
disease_progression 
H-positive risk:  800 873 125 1008 365 119 949 389 140 46 136 50 
H-negative risk:  873 800 949 1008 389 365 119 125 136 140 50 46 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 63 31 

clinical_engagement 
diagnosis 
demography 
79 new agents 
51 
disease_progression 
H-positive risk:  803 868 127 1008 368 119 939 396 139 46 135 52 
H-negative risk:  868 803 939 1008 396 368 119 127 135 139 52 46 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 63 30 

clinical_engagement 
diagnosis 
demography 
71 new agents 
52 
disease_progression 
H-positive risk:  808 880 124 990 373 120 937 395 141 45 137 50 
H-negative risk:  880 808 937 990 395 373 120 124 137 141 50 45 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 69 30 

clinical_engagement 
diagnosis 
demography 
74 new agents 
53 
disease_progression 
H-positive risk:  813 888 124 982 372 122 934 389 142 46 139 49 
H-negative risk:  888 813 934 982 389 372 122 124 139 142 49 46 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 67 30 

clinical_engagement 
diagnosis 
demography 
69 new agents 
54 
disease_progression 
H-positive risk:  819 887 121 988 373 121 938 378 144 45 139 47 
H-negative risk:  887 819 938 988 378 373 121 121 139 144 47 45 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 68 31 

clinical_engagement 
diagnosis 
demography 
60 new agents 
55 
disease_progression 
H-positive risk:  824 893 121 987 371 123 930 377 143 44 138 49 
H-negative risk:  893 824 930 987 377 371 123 121 138 143 49 44 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 70 30 

clinical_engagement 
diagnosis 
demography 
65 new agents 
56 
disease_progression 
H-positive risk:  821 897 124 980 369 125 935 377 143 43 137 49 
H-negative risk:  897 821 935 980 377 369 125 124 137 143 49 43 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 71 30 

clinical_engagement 
diagnosis 
demography 
55 new agents 
57 
disease_progression 
H-positive risk:  825 897 125 973 373 121 941 376 143 43 135 48 
H-negative risk:  897 825 941 973 376 373 121 125 135 143 48 43 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 72 30 

clinical_engagement 
diagnosis 
demography 
77 new agents 
58 
disease_progression 
H-positive risk:  825 895 121 974 372 121 947 374 145 42 138 46 
H-negative risk:  895 825 947 974 374 372 121 121 138 145 46 42 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 77 29 

clinical_engagement 
diagnosis 
demography 
75 new agents 
59 
disease_progression 
H-positive risk:  827 899 120 972 372 123 940 378 145 40 137 47 
H-negative risk:  899 827 940 972 378 372 123 120 137 145 47 40 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 78 29 

clinical_engagement 
diagnosis 
demography 
62 new agents 
60 
disease_progression 
H-positive risk:  835 902 120 972 372 122 934 376 146 40 136 45 
H-negative risk:  902 835 934 972 376 372 122 120 136 146 45 40 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 74 30 

clinical_engagement 
diagnosis 
demography 
62 new agents 
61 
disease_progression 
H-positive risk:  791 843 107 1035 361 116 981 381 153 40 149 43 
H-negative risk:  843 791 981 1035 381 361 116 107 149 153 43 40 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 75 30 

clinical_engagement 
diagnosis 
demography 
113 new agents 
62 
disease_progression 
H-positive risk:  788 837 107 1001 405 116 958 398 150 47 150 43 
H-negative risk:  837 788 958 1001 398 405 116 107 150 150 43 47 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 76 31 

clinical_engagement 
diagnosis 
demography 
73 new agents 
63 
disease_progression 
H-positive risk:  787 840 108 997 414 116 953 399 148 49 144 45 
H-negative risk:  840 787 953 997 399 414 116 108 144 148 45 49 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 79 31 

clinical_engagement 
diagnosis 
demography 
73 new agents 
64 
disease_progression 
H-positive risk:  783 837 108 996 415 115 960 403 149 48 144 42 
H-negative risk:  837 783 960 996 403 415 115 108 144 149 42 48 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 77 29 

clinical_engagement 
diagnosis 
demography 
71 new agents 
65 
disease_progression 
H-positive risk:  788 833 109 998 415 114 964 397 146 49 146 41 
H-negative risk:  833 788 964 998 397 415 114 109 146 146 41 49 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 75 28 

clinical_engagement 
diagnosis 
demography 
57 new agents 
66 
disease_progression 
H-positive risk:  785 842 111 996 413 116 966 388 146 49 147 41 
H-negative risk:  842 785 966 996 388 413 116 111 147 146 41 49 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 76 28 

clinical_engagement 
diagnosis 
demography 
54 new agents 
67 
disease_progression 
H-positive risk:  787 843 109 999 406 115 973 386 143 50 149 40 
H-negative risk:  843 787 973 999 386 406 115 109 149 143 40 50 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 76 28 

clinical_engagement 
diagnosis 
demography 
73 new agents 
68 
disease_progression 
H-positive risk:  791 848 108 995 401 115 969 386 141 54 154 38 
H-negative risk:  848 791 969 995 386 401 115 108 154 141 38 54 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 76 27 

clinical_engagement 
diagnosis 
demography 
67 new agents 
69 
disease_progression 
H-positive risk:  784 851 106 1005 397 113 977 378 143 50 158 38 
H-negative risk:  851 784 977 1005 378 397 113 106 158 143 38 50 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 73 24 

clinical_engagement 
diagnosis 
demography 
52 new agents 
70 
disease_progression 
H-positive risk:  787 849 107 1005 396 113 977 378 142 52 157 37 
H-negative risk:  849 787 977 1005 378 396 113 107 157 142 37 52 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 73 24 

clinical_engagement 
diagnosis 
demography 
68 new agents 
71 
disease_progression 
H-positive risk:  784 847 110 1005 390 112 982 378 144 51 160 37 
H-negative risk:  847 784 982 1005 378 390 112 110 160 144 37 51 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 73 24 

clinical_engagement 
diagnosis 
demography 
80 new agents 
72 
disease_progression 
H-positive risk:  788 853 111 1006 385 110 984 370 143 50 161 39 
H-negative risk:  853 788 984 1006 370 385 110 111 161 143 39 50 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 72 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
73 
disease_progression 
H-positive risk:  751 794 101 1070 392 106 1020 359 148 50 170 39 
H-negative risk:  794 751 1020 1070 359 392 106 101 170 148 39 50 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 73 25 

clinical_engagement 
diagnosis 
demography 
111 new agents 
74 
disease_progression 
H-positive risk:  758 785 101 1063 398 106 1014 370 144 50 166 45 
H-negative risk:  785 758 1014 1063 370 398 106 101 166 144 45 50 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 72 27 

clinical_engagement 
diagnosis 
demography 
81 new agents 
75 
disease_progression 
H-positive risk:  759 798 98 1062 395 104 1015 371 143 48 162 45 
H-negative risk:  798 759 1015 1062 371 395 104 98 162 143 45 48 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 71 28 

clinical_engagement 
diagnosis 
demography 
64 new agents 
76 
disease_progression 
H-positive risk:  762 798 100 1056 393 106 1014 368 146 50 163 44 
H-negative risk:  798 762 1014 1056 368 393 106 100 163 146 44 50 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 72 27 

clinical_engagement 
diagnosis 
demography 
69 new agents 
77 
disease_progression 
H-positive risk:  764 806 101 1062 383 108 1016 361 144 50 160 45 
H-negative risk:  806 764 1016 1062 361 383 108 101 160 144 45 50 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 75 25 

clinical_engagement 
diagnosis 
demography 
63 new agents 
78 
disease_progression 
H-positive risk:  771 812 102 1049 382 105 1007 369 144 52 164 43 
H-negative risk:  812 771 1007 1049 369 382 105 102 164 144 43 52 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 78 26 

clinical_engagement 
diagnosis 
demography 
69 new agents 
79 
disease_progression 
H-positive risk:  768 811 102 1042 380 109 1010 368 146 53 164 47 
H-negative risk:  811 768 1010 1042 368 380 109 102 164 146 47 53 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 78 26 

clinical_engagement 
diagnosis 
demography 
75 new agents 
80 
disease_progression 
H-positive risk:  771 810 100 1053 373 109 1013 363 146 54 164 44 
H-negative risk:  810 771 1013 1053 363 373 109 100 164 146 44 54 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 77 26 

clinical_engagement 
diagnosis 
demography 
80 new agents 
81 
disease_progression 
H-positive risk:  764 816 101 1047 374 110 1013 366 145 55 164 45 
H-negative risk:  816 764 1013 1047 366 374 110 101 164 145 45 55 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
82 
disease_progression 
H-positive risk:  770 821 102 1035 368 110 1018 370 144 53 164 45 
H-negative risk:  821 770 1018 1035 370 368 110 102 164 144 45 53 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
59 new agents 
83 
disease_progression 
H-positive risk:  771 816 102 1036 371 110 1017 369 146 53 158 51 
H-negative risk:  816 771 1017 1036 369 371 110 102 158 146 51 53 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
68 new agents 
84 
disease_progression 
H-positive risk:  776 822 104 1034 371 112 1018 357 146 53 156 51 
H-negative risk:  822 776 1018 1034 357 371 112 104 156 146 51 53 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
85 
disease_progression 
H-positive risk:  732 778 99 1091 365 106 1058 357 150 53 162 49 
H-negative risk:  778 732 1058 1091 357 365 106 99 162 150 49 53 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
105 new agents 
86 
disease_progression 
H-positive risk:  734 773 103 1066 379 105 1060 365 147 56 156 56 
H-negative risk:  773 734 1060 1066 365 379 105 103 156 147 56 56 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 79 21 

clinical_engagement 
diagnosis 
demography 
58 new agents 
87 
disease_progression 
H-positive risk:  736 769 104 1063 387 107 1052 368 144 56 154 60 
H-negative risk:  769 736 1052 1063 368 387 107 104 154 144 60 56 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
69 new agents 
88 
disease_progression 
H-positive risk:  737 770 104 1061 382 106 1056 367 144 58 156 59 
H-negative risk:  770 737 1056 1061 367 382 106 104 156 144 59 58 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
67 new agents 
89 
disease_progression 
H-positive risk:  736 768 104 1063 379 105 1059 363 149 59 156 59 
H-negative risk:  768 736 1059 1063 363 379 105 104 156 149 59 59 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 74 21 

clinical_engagement 
diagnosis 
demography 
64 new agents 
90 
disease_progression 
H-positive risk:  731 775 105 1059 382 106 1063 359 148 56 155 61 
H-negative risk:  775 731 1063 1059 359 382 106 105 155 148 61 56 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 74 20 

clinical_engagement 
diagnosis 
demography 
65 new agents 
91 
disease_progression 
H-positive risk:  730 784 104 1056 388 105 1062 357 144 55 158 57 
H-negative risk:  784 730 1062 1056 357 388 105 104 158 144 57 55 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 72 20 

clinical_engagement 
diagnosis 
demography 
82 new agents 
92 
disease_progression 
H-positive risk:  731 793 105 1052 390 103 1060 356 145 56 157 52 
H-negative risk:  793 731 1060 1052 356 390 103 105 157 145 52 56 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 70 21 

clinical_engagement 
diagnosis 
demography 
89 new agents 
93 
disease_progression 
H-positive risk:  734 791 107 1054 394 104 1052 357 145 57 152 53 
H-negative risk:  791 734 1052 1054 357 394 104 107 152 145 53 57 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 74 21 

clinical_engagement 
diagnosis 
demography 
88 new agents 
94 
disease_progression 
H-positive risk:  739 798 108 1057 394 104 1051 346 145 54 150 54 
H-negative risk:  798 739 1051 1057 346 394 104 108 150 145 54 54 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 78 20 

clinical_engagement 
diagnosis 
demography 
67 new agents 
95 
disease_progression 
H-positive risk:  745 805 107 1044 393 104 1050 353 140 58 146 55 
H-negative risk:  805 745 1050 1044 353 393 104 107 146 140 55 58 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 79 20 

clinical_engagement 
diagnosis 
demography 
69 new agents 
96 
disease_progression 
H-positive risk:  745 805 107 1051 385 105 1049 356 140 59 144 54 
H-negative risk:  805 745 1049 1051 356 385 105 107 144 140 54 59 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 79 20 

clinical_engagement 
diagnosis 
demography 
71 new agents 
97 
disease_progression 
H-positive risk:  696 740 102 1114 386 100 1097 355 149 59 149 53 
H-negative risk:  740 696 1097 1114 355 386 100 102 149 149 53 59 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 79 19 

clinical_engagement 
diagnosis 
demography 
107 new agents 
98 
disease_progression 
H-positive risk:  703 744 102 1109 380 100 1072 382 145 61 148 54 
H-negative risk:  744 703 1072 1109 382 380 100 102 148 145 54 61 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 77 21 

clinical_engagement 
diagnosis 
demography 
65 new agents 
99 
disease_progression 
H-positive risk:  709 745 101 1104 380 103 1061 390 144 61 148 54 
H-negative risk:  745 709 1061 1104 390 380 103 101 148 144 54 61 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 77 20 

clinical_engagement 
diagnosis 
demography 
61 new agents 
100 
disease_progression 
H-positive risk:  712 742 104 1098 385 104 1066 385 143 58 147 56 
H-negative risk:  742 712 1066 1098 385 385 104 104 147 143 56 58 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 80 19 

clinical_engagement 
diagnosis 
demography 
70 new agents 
101 
disease_progression 
H-positive risk:  717 731 105 1096 381 103 1076 390 142 57 146 56 
H-negative risk:  731 717 1076 1096 390 381 103 105 146 142 56 57 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 79 17 

clinical_engagement 
diagnosis 
demography 
55 new agents 
102 
disease_progression 
H-positive risk:  714 726 106 1098 387 100 1081 389 143 57 145 54 
H-negative risk:  726 714 1081 1098 389 387 100 106 145 143 54 57 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 78 18 

clinical_engagement 
diagnosis 
demography 
67 new agents 
103 
disease_progression 
H-positive risk:  713 731 106 1100 382 99 1079 389 145 58 143 55 
H-negative risk:  731 713 1079 1100 389 382 99 106 143 145 55 58 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 76 16 

clinical_engagement 
diagnosis 
demography 
68 new agents 
104 
disease_progression 
H-positive risk:  719 730 107 1092 390 99 1079 383 147 58 143 53 
H-negative risk:  730 719 1079 1092 383 390 99 107 143 147 53 58 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 75 16 

clinical_engagement 
diagnosis 
demography 
80 new agents 
105 
disease_progression 
H-positive risk:  728 728 105 1097 387 103 1072 381 146 59 141 53 
H-negative risk:  728 728 1072 1097 381 387 103 105 141 146 53 59 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 73 16 

clinical_engagement 
diagnosis 
demography 
75 new agents 
106 
disease_progression 
H-positive risk:  734 724 104 1105 385 105 1068 379 143 58 140 55 
H-negative risk:  724 734 1068 1105 379 385 105 104 140 143 55 58 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 73 15 

clinical_engagement 
diagnosis 
demography 
74 new agents 
107 
disease_progression 
H-positive risk:  734 724 104 1110 381 104 1082 375 141 56 135 54 
H-negative risk:  724 734 1082 1110 375 381 104 104 135 141 54 56 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 74 15 

clinical_engagement 
diagnosis 
demography 
60 new agents 
108 
disease_progression 
H-positive risk:  738 725 105 1111 381 103 1076 370 144 56 134 57 
H-negative risk:  725 738 1076 1111 370 381 103 105 134 144 57 56 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 76 15 

clinical_engagement 
diagnosis 
demography 
75 new agents 
109 
disease_progression 
H-positive risk:  712 676 93 1158 377 98 1113 366 150 54 146 57 
H-negative risk:  676 712 1113 1158 366 377 98 93 146 150 57 54 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 74 15 

clinical_engagement 
diagnosis 
demography 
95 new agents 
110 
disease_progression 
H-positive risk:  709 681 91 1134 395 98 1100 386 149 51 147 59 
H-negative risk:  681 709 1100 1134 386 395 98 91 147 149 59 51 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 75 15 

clinical_engagement 
diagnosis 
demography 
83 new agents 
111 
disease_progression 
H-positive risk:  711 681 94 1133 392 97 1098 393 148 50 146 57 
H-negative risk:  681 711 1098 1133 393 392 97 94 146 148 57 50 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 71 17 

clinical_engagement 
diagnosis 
demography 
72 new agents 
112 
disease_progression 
H-positive risk:  707 677 94 1148 384 100 1100 390 148 50 147 55 
H-negative risk:  677 707 1100 1148 390 384 100 94 147 148 55 50 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 72 18 

clinical_engagement 
diagnosis 
demography 
77 new agents 
113 
disease_progression 
H-positive risk:  700 672 94 1153 383 100 1110 389 148 49 145 57 
H-negative risk:  672 700 1110 1153 389 383 100 94 145 148 57 49 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 76 18 

clinical_engagement 
diagnosis 
demography 
70 new agents 
114 
disease_progression 
H-positive risk:  701 669 96 1152 384 99 1104 397 146 47 145 60 
H-negative risk:  669 701 1104 1152 397 384 99 96 145 146 60 47 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 79 18 

clinical_engagement 
diagnosis 
demography 
70 new agents 
115 
disease_progression 
H-positive risk:  704 671 97 1151 385 100 1106 392 145 49 145 55 
H-negative risk:  671 704 1106 1151 392 385 100 97 145 145 55 49 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 80 18 

clinical_engagement 
diagnosis 
demography 
73 new agents 
116 
disease_progression 
H-positive risk:  707 669 98 1156 377 100 1109 398 142 49 143 52 
H-negative risk:  669 707 1109 1156 398 377 100 98 143 142 52 49 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 79 21 

clinical_engagement 
diagnosis 
demography 
65 new agents 
117 
disease_progression 
H-positive risk:  701 663 99 1162 373 101 1114 398 144 50 144 51 
H-negative risk:  663 701 1114 1162 398 373 101 99 144 144 51 50 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
80 new agents 
118 
disease_progression 
H-positive risk:  703 662 97 1169 365 99 1115 400 146 49 144 51 
H-negative risk:  662 703 1115 1169 400 365 99 97 144 146 51 49 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 82 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
119 
disease_progression 
H-positive risk:  709 666 97 1175 358 100 1119 390 145 46 145 50 
H-negative risk:  666 709 1119 1175 390 358 100 97 145 145 50 46 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
60 new agents 
120 
disease_progression 
H-positive risk:  711 657 96 1177 363 102 1119 395 145 44 144 47 
H-negative risk:  657 711 1119 1177 395 363 102 96 144 145 47 44 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
92 new agents 
121 
disease_progression 
H-positive risk:  677 609 94 1218 369 100 1151 389 152 43 152 46 
H-negative risk:  609 677 1151 1218 389 369 100 94 152 152 46 43 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
97 new agents 
122 
disease_progression 
H-positive risk:  686 612 99 1220 367 102 1126 395 152 42 152 47 
H-negative risk:  612 686 1126 1220 395 367 102 99 152 152 47 42 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
79 new agents 
123 
disease_progression 
H-positive risk:  688 617 99 1205 373 102 1127 395 151 42 150 51 
H-negative risk:  617 688 1127 1205 395 373 102 99 150 151 51 42 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 80 20 

clinical_engagement 
diagnosis 
demography 
69 new agents 
124 
disease_progression 
H-positive risk:  682 616 100 1204 375 101 1132 397 153 39 151 50 
H-negative risk:  616 682 1132 1204 397 375 101 100 151 153 50 39 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
79 new agents 
125 
disease_progression 
H-positive risk:  689 614 100 1200 372 102 1134 401 152 38 147 51 
H-negative risk:  614 689 1134 1200 401 372 102 100 147 152 51 38 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 77 20 

clinical_engagement 
diagnosis 
demography 
77 new agents 
126 
disease_progression 
H-positive risk:  693 618 102 1187 369 104 1134 406 151 39 146 51 
H-negative risk:  618 693 1134 1187 406 369 104 102 146 151 51 39 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 79 20 

clinical_engagement 
diagnosis 
demography 
83 new agents 
127 
disease_progression 
H-positive risk:  704 620 106 1186 362 103 1129 409 151 38 140 52 
H-negative risk:  620 704 1129 1186 409 362 103 106 140 151 52 38 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 80 20 

clinical_engagement 
diagnosis 
demography 
73 new agents 
128 
disease_progression 
H-positive risk:  702 623 105 1190 368 100 1126 407 150 38 140 51 
H-negative risk:  623 702 1126 1190 407 368 100 105 140 150 51 38 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 81 19 

clinical_engagement 
diagnosis 
demography 
71 new agents 
129 
disease_progression 
H-positive risk:  706 619 106 1197 369 101 1119 402 146 40 142 53 
H-negative risk:  619 706 1119 1197 402 369 101 106 142 146 53 40 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 79 19 

clinical_engagement 
diagnosis 
demography 
72 new agents 
130 
disease_progression 
H-positive risk:  704 622 108 1204 364 101 1116 404 148 40 138 51 
H-negative risk:  622 704 1116 1204 404 364 101 108 138 148 51 40 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 79 18 

clinical_engagement 
diagnosis 
demography 
72 new agents 
131 
disease_progression 
H-positive risk:  712 620 104 1206 365 102 1115 396 146 41 140 53 
H-negative risk:  620 712 1115 1206 396 365 102 104 140 146 53 41 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 78 18 

clinical_engagement 
diagnosis 
demography 
82 new agents 
132 
disease_progression 
H-positive risk:  711 631 107 1198 362 101 1118 395 149 38 137 53 
H-negative risk:  631 711 1118 1198 395 362 101 107 137 149 53 38 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
70 new agents 
133 
disease_progression 
H-positive risk:  709 638 110 1190 363 101 1122 394 150 37 135 51 
H-negative risk:  638 709 1122 1190 394 363 101 110 135 150 51 37 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 82 17 

clinical_engagement 
diagnosis 
demography 
91 new agents 
134 
disease_progression 
H-positive risk:  709 629 111 1193 368 99 1105 406 154 39 132 55 
H-negative risk:  629 709 1105 1193 406 368 99 111 132 154 55 39 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 82 18 

clinical_engagement 
diagnosis 
demography 
62 new agents 
135 
disease_progression 
H-positive risk:  700 640 111 1197 368 98 1103 399 156 39 134 55 
H-negative risk:  640 700 1103 1197 399 368 98 111 134 156 55 39 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 79 19 

clinical_engagement 
diagnosis 
demography 
71 new agents 
136 
disease_progression 
H-positive risk:  708 643 110 1192 372 98 1097 397 159 36 132 56 
H-negative risk:  643 708 1097 1192 397 372 98 110 132 159 56 36 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 79 19 

clinical_engagement 
diagnosis 
demography 
60 new agents 
137 
disease_progression 
H-positive risk:  708 636 110 1189 377 98 1101 401 160 36 127 57 
H-negative risk:  636 708 1101 1189 401 377 98 110 127 160 57 36 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 80 19 

clinical_engagement 
diagnosis 
demography 
80 new agents 
138 
disease_progression 
H-positive risk:  709 638 112 1195 376 96 1094 401 161 37 126 55 
H-negative risk:  638 709 1094 1195 401 376 96 112 126 161 55 37 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
72 new agents 
139 
disease_progression 
H-positive risk:  703 635 116 1199 374 97 1094 404 163 37 122 56 
H-negative risk:  635 703 1094 1199 404 374 97 116 122 163 56 37 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 78 20 

clinical_engagement 
diagnosis 
demography 
88 new agents 
140 
disease_progression 
H-positive risk:  705 636 120 1191 369 97 1102 400 165 37 122 56 
H-negative risk:  636 705 1102 1191 400 369 97 120 122 165 56 37 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 82 19 

clinical_engagement 
diagnosis 
demography 
73 new agents 
141 
disease_progression 
H-positive risk:  705 633 119 1194 375 98 1101 392 166 37 124 56 
H-negative risk:  633 705 1101 1194 392 375 98 119 124 166 56 37 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 79 19 

clinical_engagement 
diagnosis 
demography 
92 new agents 
142 
disease_progression 
H-positive risk:  703 637 121 1180 373 103 1109 396 165 37 122 54 
H-negative risk:  637 703 1109 1180 396 373 103 121 122 165 54 37 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 81 19 

clinical_engagement 
diagnosis 
demography 
91 new agents 
143 
disease_progression 
H-positive risk:  707 644 120 1169 375 104 1106 398 160 39 124 54 
H-negative risk:  644 707 1106 1169 398 375 104 120 124 160 54 39 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 81 19 

clinical_engagement 
diagnosis 
demography 
60 new agents 
144 
disease_progression 
H-positive risk:  702 642 118 1171 379 103 1105 400 161 39 128 52 
H-negative risk:  642 702 1105 1171 400 379 103 118 128 161 52 39 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 79 19 

clinical_engagement 
diagnosis 
demography 
71 new agents 
145 
disease_progression 
H-positive risk:  703 646 116 1162 384 103 1106 397 161 39 130 53 
H-negative risk:  646 703 1106 1162 397 384 103 116 130 161 53 39 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
91 new agents 
146 
disease_progression 
H-positive risk:  703 641 115 1153 399 103 1101 399 161 41 129 55 
H-negative risk:  641 703 1101 1153 399 399 103 115 129 161 55 41 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 78 18 

clinical_engagement 
diagnosis 
demography 
72 new agents 
147 
disease_progression 
H-positive risk:  699 652 117 1147 402 100 1101 400 156 44 126 56 
H-negative risk:  652 699 1101 1147 400 402 100 117 126 156 56 44 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 79 18 

clinical_engagement 
diagnosis 
demography 
65 new agents 
148 
disease_progression 
H-positive risk:  690 651 116 1147 403 102 1103 400 158 45 125 60 
H-negative risk:  651 690 1103 1147 400 403 102 116 125 158 60 45 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 79 18 

clinical_engagement 
diagnosis 
demography 
83 new agents 
149 
disease_progression 
H-positive risk:  686 663 116 1137 403 100 1105 405 161 44 122 58 
H-negative risk:  663 686 1105 1137 405 403 100 116 122 161 58 44 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 82 18 

clinical_engagement 
diagnosis 
demography 
83 new agents 
150 
disease_progression 
H-positive risk:  681 668 115 1137 398 101 1109 401 163 46 123 58 
H-negative risk:  668 681 1109 1137 401 398 101 115 123 163 58 46 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 79 18 

clinical_engagement 
diagnosis 
demography 
78 new agents 
151 
disease_progression 
H-positive risk:  681 670 114 1137 399 101 1106 398 165 47 123 59 
H-negative risk:  670 681 1106 1137 398 399 101 114 123 165 59 47 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 77 19 

clinical_engagement 
diagnosis 
demography 
77 new agents 
152 
disease_progression 
H-positive risk:  685 670 114 1139 401 102 1101 397 160 48 124 59 
H-negative risk:  670 685 1101 1139 397 401 102 114 124 160 59 48 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
70 new agents 
153 
disease_progression 
H-positive risk:  686 683 113 1129 403 100 1103 386 164 49 125 59 
H-negative risk:  683 686 1103 1129 386 403 100 113 125 164 59 49 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 80 19 

clinical_engagement 
diagnosis 
demography 
69 new agents 
154 
disease_progression 
H-positive risk:  683 691 113 1126 402 101 1105 385 164 46 123 61 
H-negative risk:  691 683 1105 1126 385 402 101 113 123 164 61 46 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 79 20 

clinical_engagement 
diagnosis 
demography 
58 new agents 
155 
disease_progression 
H-positive risk:  676 693 114 1117 403 102 1114 390 163 46 123 59 
H-negative risk:  693 676 1114 1117 390 403 102 114 123 163 59 46 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 82 21 

clinical_engagement 
diagnosis 
demography 
68 new agents 
156 
disease_progression 
H-positive risk:  680 701 113 1110 401 98 1108 395 163 48 124 59 
H-negative risk:  701 680 1108 1110 395 401 98 113 124 163 59 48 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 88 20 

clinical_engagement 
diagnosis 
demography 
71 new agents 
157 
disease_progression 
H-positive risk:  662 702 114 1120 397 96 1122 385 167 50 127 58 
H-negative risk:  702 662 1122 1120 385 397 96 114 127 167 58 50 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 86 20 

clinical_engagement 
diagnosis 
demography 
104 new agents 
158 
disease_progression 
H-positive risk:  661 707 113 1111 407 101 1124 380 158 53 128 57 
H-negative risk:  707 661 1124 1111 380 407 101 113 128 158 57 53 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 86 20 

clinical_engagement 
diagnosis 
demography 
73 new agents 
159 
disease_progression 
H-positive risk:  658 704 112 1119 410 100 1123 376 158 52 130 58 
H-negative risk:  704 658 1123 1119 376 410 100 112 130 158 58 52 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
71 new agents 
160 
disease_progression 
H-positive risk:  662 708 112 1121 409 100 1117 375 154 53 129 60 
H-negative risk:  708 662 1117 1121 375 409 100 112 129 154 60 53 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 88 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
161 
disease_progression 
H-positive risk:  664 705 112 1125 409 98 1114 370 160 54 131 58 
H-negative risk:  705 664 1114 1125 370 409 98 112 131 160 58 54 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 84 20 

clinical_engagement 
diagnosis 
demography 
87 new agents 
162 
disease_progression 
H-positive risk:  664 707 112 1136 404 99 1111 367 155 56 132 57 
H-negative risk:  707 664 1111 1136 367 404 99 112 132 155 57 56 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 87 20 

clinical_engagement 
diagnosis 
demography 
62 new agents 
163 
disease_progression 
H-positive risk:  663 711 113 1127 402 100 1108 371 156 59 134 56 
H-negative risk:  711 663 1108 1127 371 402 100 113 134 156 56 59 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 88 21 

clinical_engagement 
diagnosis 
demography 
70 new agents 
164 
disease_progression 
H-positive risk:  663 711 110 1139 394 102 1111 367 157 56 136 54 
H-negative risk:  711 663 1111 1139 367 394 102 110 136 157 54 56 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 88 21 

clinical_engagement 
diagnosis 
demography 
66 new agents 
165 
disease_progression 
H-positive risk:  667 716 110 1133 397 101 1109 366 156 54 135 56 
H-negative risk:  716 667 1109 1133 366 397 101 110 135 156 56 54 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 90 21 

clinical_engagement 
diagnosis 
demography 
82 new agents 
166 
disease_progression 
H-positive risk:  670 723 108 1134 392 102 1099 374 155 53 138 52 
H-negative risk:  723 670 1099 1134 374 392 102 108 138 155 52 53 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 88 22 

clinical_engagement 
diagnosis 
demography 
67 new agents 
167 
disease_progression 
H-positive risk:  662 716 109 1144 397 100 1094 381 157 52 134 54 
H-negative risk:  716 662 1094 1144 381 397 100 109 134 157 54 52 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 86 21 

clinical_engagement 
diagnosis 
demography 
68 new agents 
168 
disease_progression 
H-positive risk:  655 715 108 1143 393 102 1108 379 158 53 133 53 
H-negative risk:  715 655 1108 1143 379 393 102 108 133 158 53 53 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 84 21 

clinical_engagement 
diagnosis 
demography 
66 new agents 
169 
disease_progression 
H-positive risk:  652 715 105 1142 393 102 1106 386 160 54 135 50 
H-negative risk:  715 652 1106 1142 386 393 102 105 135 160 50 54 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
77 new agents 
170 
disease_progression 
H-positive risk:  650 714 106 1140 394 102 1098 396 151 63 135 51 
H-negative risk:  714 650 1098 1140 396 394 102 106 135 151 51 63 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
82 new agents 
171 
disease_progression 
H-positive risk:  643 709 104 1142 393 104 1109 395 153 58 138 52 
H-negative risk:  709 643 1109 1142 395 393 104 104 138 153 52 58 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
60 new agents 
172 
disease_progression 
H-positive risk:  647 701 103 1135 398 101 1112 403 153 57 137 53 
H-negative risk:  701 647 1112 1135 403 398 101 103 137 153 53 57 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 90 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
173 
disease_progression 
H-positive risk:  649 704 106 1138 399 100 1112 400 152 56 134 50 
H-negative risk:  704 649 1112 1138 400 399 100 106 134 152 50 56 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 88 23 

clinical_engagement 
diagnosis 
demography 
86 new agents 
174 
disease_progression 
H-positive risk:  654 705 108 1144 395 101 1106 397 152 57 136 45 
H-negative risk:  705 654 1106 1144 397 395 101 108 136 152 45 57 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 91 21 

clinical_engagement 
diagnosis 
demography 
86 new agents 
175 
disease_progression 
H-positive risk:  656 707 103 1144 394 96 1108 394 159 55 137 47 
H-negative risk:  707 656 1108 1144 394 394 96 103 137 159 47 55 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 94 21 

clinical_engagement 
diagnosis 
demography 
69 new agents 
176 
disease_progression 
H-positive risk:  659 701 103 1146 408 96 1096 395 158 53 136 49 
H-negative risk:  701 659 1096 1146 395 408 96 103 136 158 49 53 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 94 21 

clinical_engagement 
diagnosis 
demography 
75 new agents 
177 
disease_progression 
H-positive risk:  657 701 106 1156 401 94 1094 393 158 55 137 48 
H-negative risk:  701 657 1094 1156 393 401 94 106 137 158 48 55 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 93 21 

clinical_engagement 
diagnosis 
demography 
78 new agents 
178 
disease_progression 
H-positive risk:  656 700 107 1157 398 94 1094 394 156 57 138 49 
H-negative risk:  700 656 1094 1157 394 398 94 107 138 156 49 57 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 94 22 

clinical_engagement 
diagnosis 
demography 
61 new agents 
179 
disease_progression 
H-positive risk:  655 697 105 1152 402 94 1091 399 158 58 139 50 
H-negative risk:  697 655 1091 1152 399 402 94 105 139 158 50 58 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 94 23 

clinical_engagement 
diagnosis 
demography 
87 new agents 
180 
disease_progression 
H-positive risk:  659 706 107 1146 392 95 1094 391 158 59 141 52 
H-negative risk:  706 659 1094 1146 391 392 95 107 141 158 52 59 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 91 23 

clinical_engagement 
diagnosis 
demography 
72 new agents 
181 
disease_progression 
H-positive risk:  664 698 106 1151 395 96 1089 395 156 57 142 51 
H-negative risk:  698 664 1089 1151 395 395 96 106 142 156 51 57 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 92 24 

clinical_engagement 
diagnosis 
demography 
77 new agents 
182 
disease_progression 
H-positive risk:  653 693 106 1148 413 98 1078 403 155 59 141 53 
H-negative risk:  693 653 1078 1148 403 413 98 106 141 155 53 59 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 90 25 

clinical_engagement 
diagnosis 
demography 
82 new agents 
183 
disease_progression 
H-positive risk:  665 700 106 1135 416 100 1073 398 152 61 141 53 
H-negative risk:  700 665 1073 1135 398 416 100 106 141 152 53 61 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 90 24 

clinical_engagement 
diagnosis 
demography 
80 new agents 
184 
disease_progression 
H-positive risk:  667 708 107 1136 404 102 1068 409 152 59 140 48 
H-negative risk:  708 667 1068 1136 409 404 102 107 140 152 48 59 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 88 24 

clinical_engagement 
diagnosis 
demography 
85 new agents 
185 
disease_progression 
H-positive risk:  663 714 103 1138 404 101 1070 401 153 60 144 49 
H-negative risk:  714 663 1070 1138 401 404 101 103 144 153 49 60 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 90 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
186 
disease_progression 
H-positive risk:  667 716 105 1141 407 101 1062 397 152 58 145 49 
H-negative risk:  716 667 1062 1141 397 407 101 105 145 152 49 58 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 91 22 

clinical_engagement 
diagnosis 
demography 
70 new agents 
187 
disease_progression 
H-positive risk:  671 712 104 1140 410 101 1063 392 153 58 144 52 
H-negative risk:  712 671 1063 1140 392 410 101 104 144 153 52 58 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 91 22 

clinical_engagement 
diagnosis 
demography 
66 new agents 
188 
disease_progression 
H-positive risk:  676 713 105 1133 413 100 1058 395 152 62 142 51 
H-negative risk:  713 676 1058 1133 395 413 100 105 142 152 51 62 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 90 23 

clinical_engagement 
diagnosis 
demography 
87 new agents 
189 
disease_progression 
H-positive risk:  673 719 105 1136 405 95 1062 395 157 60 144 49 
H-negative risk:  719 673 1062 1136 395 405 95 105 144 157 49 60 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
67 new agents 
190 
disease_progression 
H-positive risk:  673 716 106 1138 398 95 1061 403 153 63 143 51 
H-negative risk:  716 673 1061 1138 403 398 95 106 143 153 51 63 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 86 24 

clinical_engagement 
diagnosis 
demography 
93 new agents 
191 
disease_progression 
H-positive risk:  675 715 106 1131 399 97 1055 411 154 62 145 50 
H-negative risk:  715 675 1055 1131 411 399 97 106 145 154 50 62 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 90 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
192 
disease_progression 
H-positive risk:  689 716 106 1129 398 97 1049 411 150 63 145 47 
H-negative risk:  716 689 1049 1129 411 398 97 106 145 150 47 63 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 91 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
193 
disease_progression 
H-positive risk:  692 718 108 1132 389 101 1041 413 151 63 144 48 
H-negative risk:  718 692 1041 1132 413 389 101 108 144 151 48 63 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 90 22 

clinical_engagement 
diagnosis 
demography 
84 new agents 
194 
disease_progression 
H-positive risk:  696 721 107 1108 412 100 1033 418 152 62 144 47 
H-negative risk:  721 696 1033 1108 418 412 100 107 144 152 47 62 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 87 22 

clinical_engagement 
diagnosis 
demography 
79 new agents 
195 
disease_progression 
H-positive risk:  697 718 106 1116 412 100 1032 412 154 63 143 47 
H-negative risk:  718 697 1032 1116 412 412 100 106 143 154 47 63 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 88 22 

clinical_engagement 
diagnosis 
demography 
62 new agents 
196 
disease_progression 
H-positive risk:  695 719 106 1107 412 100 1032 416 152 66 149 46 
H-negative risk:  719 695 1032 1107 416 412 100 106 149 152 46 66 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 90 22 

clinical_engagement 
diagnosis 
demography 
58 new agents 
197 
disease_progression 
H-positive risk:  694 724 104 1114 411 97 1030 414 151 68 149 44 
H-negative risk:  724 694 1030 1114 414 411 97 104 149 151 44 68 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 87 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
198 
disease_progression 
H-positive risk:  693 715 107 1125 407 99 1027 417 151 67 149 43 
H-negative risk:  715 693 1027 1125 417 407 99 107 149 151 43 67 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
90 new agents 
199 
disease_progression 
H-positive risk:  700 715 106 1116 399 102 1029 418 154 68 149 44 
H-negative risk:  715 700 1029 1116 418 399 102 106 149 154 44 68 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 84 23 

clinical_engagement 
diagnosis 
demography 
59 new agents 
200 
disease_progression 
H-positive risk:  691 701 106 1131 402 102 1038 420 149 70 146 44 
H-negative risk:  701 691 1038 1131 420 402 102 106 146 149 44 70 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
201 
disease_progression 
H-positive risk:  702 695 106 1141 394 103 1041 416 148 67 146 41 
H-negative risk:  695 702 1041 1141 416 394 103 106 146 148 41 67 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 85 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
202 
disease_progression 
H-positive risk:  693 689 105 1150 395 101 1045 411 151 66 150 44 
H-negative risk:  689 693 1045 1150 411 395 101 105 150 151 44 66 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 87 23 

clinical_engagement 
diagnosis 
demography 
66 new agents 
203 
disease_progression 
H-positive risk:  697 687 104 1146 390 100 1051 413 152 65 151 44 
H-negative risk:  687 697 1051 1146 413 390 100 104 151 152 44 65 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
204 
disease_progression 
H-positive risk:  693 696 102 1142 387 98 1061 403 155 64 151 48 
H-negative risk:  696 693 1061 1142 403 387 98 102 151 155 48 64 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
77 new agents 
205 
disease_progression 
H-positive risk:  693 695 103 1143 385 98 1067 401 150 65 153 47 
H-negative risk:  695 693 1067 1143 401 385 98 103 153 150 47 65 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
86 new agents 
206 
disease_progression 
H-positive risk:  699 698 103 1134 397 98 1057 401 149 63 153 48 
H-negative risk:  698 699 1057 1134 401 397 98 103 153 149 48 63 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
87 new agents 
207 
disease_progression 
H-positive risk:  696 697 103 1130 395 99 1065 402 149 64 152 48 
H-negative risk:  697 696 1065 1130 402 395 99 103 152 149 48 64 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
76 new agents 
208 
disease_progression 
H-positive risk:  697 707 103 1114 406 96 1069 393 148 64 155 48 
H-negative risk:  707 697 1069 1114 393 406 96 103 155 148 48 64 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 83 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
209 
disease_progression 
H-positive risk:  697 703 106 1116 405 97 1071 390 150 64 154 47 
H-negative risk:  703 697 1071 1116 390 405 97 106 154 150 47 64 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
86 new agents 
210 
disease_progression 
H-positive risk:  699 708 108 1116 401 102 1059 394 148 64 153 48 
H-negative risk:  708 699 1059 1116 394 401 102 108 153 148 48 64 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
78 new agents 
211 
disease_progression 
H-positive risk:  689 707 108 1119 403 99 1070 394 148 62 154 47 
H-negative risk:  707 689 1070 1119 394 403 99 108 154 148 47 62 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
66 new agents 
212 
disease_progression 
H-positive risk:  687 704 107 1116 410 99 1072 389 150 61 159 46 
H-negative risk:  704 687 1072 1116 389 410 99 107 159 150 46 61 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
213 
disease_progression 
H-positive risk:  676 700 110 1124 414 102 1067 394 151 59 159 44 
H-negative risk:  700 676 1067 1124 394 414 102 110 159 151 44 59 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
71 new agents 
214 
disease_progression 
H-positive risk:  670 698 111 1119 422 101 1067 394 154 61 159 44 
H-negative risk:  698 670 1067 1119 394 422 101 111 159 154 44 61 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
215 
disease_progression 
H-positive risk:  671 707 111 1108 413 102 1069 396 157 61 159 46 
H-negative risk:  707 671 1069 1108 396 413 102 111 159 157 46 61 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 86 24 

clinical_engagement 
diagnosis 
demography 
67 new agents 
216 
disease_progression 
H-positive risk:  677 699 110 1103 412 104 1066 404 158 62 157 48 
H-negative risk:  699 677 1066 1103 404 412 104 110 157 158 48 62 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
217 
disease_progression 
H-positive risk:  678 691 107 1097 421 104 1058 417 158 62 157 50 
H-negative risk:  691 678 1058 1097 417 421 104 107 157 158 50 62 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 85 27 

clinical_engagement 
diagnosis 
demography 
80 new agents 
218 
disease_progression 
H-positive risk:  676 691 107 1099 417 107 1059 415 159 61 157 52 
H-negative risk:  691 676 1059 1099 415 417 107 107 157 159 52 61 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 86 26 

clinical_engagement 
diagnosis 
demography 
66 new agents 
219 
disease_progression 
H-positive risk:  671 696 107 1094 420 106 1068 406 158 62 159 53 
H-negative risk:  696 671 1068 1094 406 420 106 107 159 158 53 62 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 86 26 

clinical_engagement 
diagnosis 
demography 
85 new agents 
220 
disease_progression 
H-positive risk:  673 698 106 1098 423 105 1061 404 160 58 160 54 
H-negative risk:  698 673 1061 1098 404 423 105 106 160 160 54 58 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 88 27 

clinical_engagement 
diagnosis 
demography 
85 new agents 
221 
disease_progression 
H-positive risk:  678 701 109 1097 422 105 1062 399 158 56 158 55 
H-negative risk:  701 678 1062 1097 399 422 105 109 158 158 55 56 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 83 26 

clinical_engagement 
diagnosis 
demography 
82 new agents 
222 
disease_progression 
H-positive risk:  672 707 107 1096 418 107 1069 400 153 54 162 55 
H-negative risk:  707 672 1069 1096 400 418 107 107 162 153 55 54 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
223 
disease_progression 
H-positive risk:  678 699 108 1092 417 107 1074 401 155 52 162 55 
H-negative risk:  699 678 1074 1092 401 417 107 108 162 155 55 52 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
67 new agents 
224 
disease_progression 
H-positive risk:  685 700 108 1084 420 106 1073 401 155 50 162 56 
H-negative risk:  700 685 1073 1084 401 420 106 108 162 155 56 50 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 83 25 

clinical_engagement 
diagnosis 
demography 
79 new agents 
225 
disease_progression 
H-positive risk:  696 692 109 1091 416 108 1069 398 156 48 159 58 
H-negative risk:  692 696 1069 1091 398 416 108 109 159 156 58 48 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 84 26 

clinical_engagement 
diagnosis 
demography 
69 new agents 
226 
disease_progression 
H-positive risk:  704 682 109 1092 421 107 1068 398 158 44 159 58 
H-negative risk:  682 704 1068 1092 398 421 107 109 159 158 58 44 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
70 new agents 
227 
disease_progression 
H-positive risk:  712 670 111 1099 420 109 1061 398 161 43 158 58 
H-negative risk:  670 712 1061 1099 398 420 109 111 158 161 58 43 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
85 new agents 
228 
disease_progression 
H-positive risk:  718 672 111 1098 413 107 1061 399 160 43 159 59 
H-negative risk:  672 718 1061 1098 399 413 107 111 159 160 59 43 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 85 23 

clinical_engagement 
diagnosis 
demography 
84 new agents 
229 
disease_progression 
H-positive risk:  723 666 108 1094 419 106 1047 407 163 47 162 58 
H-negative risk:  666 723 1047 1094 407 419 106 108 162 163 58 47 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 84 20 

clinical_engagement 
diagnosis 
demography 
73 new agents 
230 
disease_progression 
H-positive risk:  713 668 110 1103 419 103 1049 400 166 47 166 56 
H-negative risk:  668 713 1049 1103 400 419 103 110 166 166 56 47 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 86 20 

clinical_engagement 
diagnosis 
demography 
84 new agents 
231 
disease_progression 
H-positive risk:  707 672 110 1104 424 101 1046 400 164 50 166 56 
H-negative risk:  672 707 1046 1104 400 424 101 110 166 164 56 50 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
75 new agents 
232 
disease_progression 
H-positive risk:  706 672 108 1104 419 102 1051 401 167 52 163 55 
H-negative risk:  672 706 1051 1104 401 419 102 108 163 167 55 52 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 83 19 

clinical_engagement 
diagnosis 
demography 
82 new agents 
233 
disease_progression 
H-positive risk:  708 668 105 1110 413 103 1043 408 170 51 166 55 
H-negative risk:  668 708 1043 1110 408 413 103 105 166 170 55 51 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
69 new agents 
234 
disease_progression 
H-positive risk:  705 665 103 1110 417 103 1039 414 170 52 168 54 
H-negative risk:  665 705 1039 1110 414 417 103 103 168 170 54 52 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
80 new agents 
235 
disease_progression 
H-positive risk:  699 668 104 1108 416 103 1031 423 170 55 169 54 
H-negative risk:  668 699 1031 1108 423 416 103 104 169 170 54 55 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
72 new agents 
236 
disease_progression 
H-positive risk:  698 666 107 1099 420 102 1036 423 168 59 169 53 
H-negative risk:  666 698 1036 1099 423 420 102 107 169 168 53 59 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 87 21 

clinical_engagement 
diagnosis 
demography 
71 new agents 
237 
disease_progression 
H-positive risk:  709 667 102 1089 424 101 1033 425 167 62 170 51 
H-negative risk:  667 709 1033 1089 425 424 101 102 170 167 51 62 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 87 22 

clinical_engagement 
diagnosis 
demography 
80 new agents 
238 
disease_progression 
H-positive risk:  709 658 100 1106 429 97 1032 416 168 64 168 53 
H-negative risk:  658 709 1032 1106 416 429 97 100 168 168 53 64 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 88 23 

clinical_engagement 
diagnosis 
demography 
81 new agents 
239 
disease_progression 
H-positive risk:  714 661 99 1099 431 96 1029 418 167 62 168 56 
H-negative risk:  661 714 1029 1099 418 431 96 99 168 167 56 62 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 92 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
240 
disease_progression 
H-positive risk:  718 660 98 1111 425 94 1025 417 167 61 167 57 
H-negative risk:  660 718 1025 1111 417 425 94 98 167 167 57 61 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 90 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
241 
disease_progression 
H-positive risk:  718 657 91 1098 443 92 1015 429 166 61 171 59 
H-negative risk:  657 718 1015 1098 429 443 92 91 171 166 59 61 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 90 24 

clinical_engagement 
diagnosis 
demography 
92 new agents 
242 
disease_progression 
H-positive risk:  717 667 91 1096 445 91 1019 414 169 61 170 60 
H-negative risk:  667 717 1019 1096 414 445 91 91 170 169 60 61 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 91 26 

clinical_engagement 
diagnosis 
demography 
82 new agents 
243 
disease_progression 
H-positive risk:  716 662 93 1107 439 92 1015 415 170 59 172 60 
H-negative risk:  662 716 1015 1107 415 439 92 93 172 170 60 59 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 89 25 

clinical_engagement 
diagnosis 
demography 
82 new agents 
244 
disease_progression 
H-positive risk:  721 665 91 1097 434 92 1022 418 170 59 175 56 
H-negative risk:  665 721 1022 1097 418 434 92 91 175 170 56 59 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 88 26 

clinical_engagement 
diagnosis 
demography 
75 new agents 
245 
disease_progression 
H-positive risk:  725 667 91 1103 432 93 1015 416 169 58 172 59 
H-negative risk:  667 725 1015 1103 416 432 93 91 172 169 59 58 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 87 26 

clinical_engagement 
diagnosis 
demography 
75 new agents 
246 
disease_progression 
H-positive risk:  729 670 90 1100 431 91 1015 416 172 58 169 59 
H-negative risk:  670 729 1015 1100 416 431 91 90 169 172 59 58 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 87 27 

clinical_engagement 
diagnosis 
demography 
74 new agents 
247 
disease_progression 
H-positive risk:  731 665 89 1104 435 94 1021 401 171 55 170 64 
H-negative risk:  665 731 1021 1104 401 435 94 89 170 171 64 55 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 84 26 

clinical_engagement 
diagnosis 
demography 
92 new agents 
248 
disease_progression 
H-positive risk:  732 676 89 1101 438 92 1019 396 172 56 169 60 
H-negative risk:  676 732 1019 1101 396 438 92 89 169 172 60 56 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 86 26 

clinical_engagement 
diagnosis 
demography 
88 new agents 
249 
disease_progression 
H-positive risk:  728 680 88 1104 437 90 1018 397 177 56 168 57 
H-negative risk:  680 728 1018 1104 397 437 90 88 168 177 57 56 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 85 25 

clinical_engagement 
diagnosis 
demography 
66 new agents 
250 
disease_progression 
H-positive risk:  722 680 88 1097 445 92 1019 398 180 55 167 57 
H-negative risk:  680 722 1019 1097 398 445 92 88 167 180 57 55 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 86 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
251 
disease_progression 
H-positive risk:  723 681 87 1089 445 93 1027 399 178 56 166 56 
H-negative risk:  681 723 1027 1089 399 445 93 87 166 178 56 56 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 84 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
252 
disease_progression 
H-positive risk:  719 677 83 1095 452 94 1033 396 172 57 166 56 
H-negative risk:  677 719 1033 1095 396 452 94 83 166 172 56 57 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 84 28 

clinical_engagement 
diagnosis 
demography 
89 new agents 
253 
disease_progression 
H-positive risk:  713 683 83 1090 458 96 1031 401 169 56 163 57 
H-negative risk:  683 713 1031 1090 401 458 96 83 163 169 57 56 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 85 28 

clinical_engagement 
diagnosis 
demography 
84 new agents 
254 
disease_progression 
H-positive risk:  721 679 78 1100 449 94 1024 405 171 58 163 58 
H-negative risk:  679 721 1024 1100 405 449 94 78 163 171 58 58 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 87 26 

clinical_engagement 
diagnosis 
demography 
63 new agents 
255 
disease_progression 
H-positive risk:  726 682 77 1093 454 93 1019 404 173 59 162 58 
H-negative risk:  682 726 1019 1093 404 454 93 77 162 173 58 59 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 86 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
256 
disease_progression 
H-positive risk:  728 683 75 1094 451 93 1014 410 173 57 164 58 
H-negative risk:  683 728 1014 1094 410 451 93 75 164 173 58 57 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 85 26 

clinical_engagement 
diagnosis 
demography 
56 new agents 
257 
disease_progression 
H-positive risk:  728 680 75 1100 444 93 1023 412 171 57 160 57 
H-negative risk:  680 728 1023 1100 412 444 93 75 160 171 57 57 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 85 27 

clinical_engagement 
diagnosis 
demography 
82 new agents 
258 
disease_progression 
H-positive risk:  736 687 72 1100 439 92 1014 413 170 54 165 58 
H-negative risk:  687 736 1014 1100 413 439 92 72 165 170 58 54 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 87 27 

clinical_engagement 
diagnosis 
demography 
72 new agents 
259 
disease_progression 
H-positive risk:  739 686 73 1108 428 94 1014 414 166 56 165 57 
H-negative risk:  686 739 1014 1108 414 428 94 73 165 166 57 56 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 84 29 

clinical_engagement 
diagnosis 
demography 
76 new agents 
260 
disease_progression 
H-positive risk:  740 690 71 1104 420 96 1022 417 162 58 164 56 
H-negative risk:  690 740 1022 1104 417 420 96 71 164 162 56 58 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 88 28 

clinical_engagement 
diagnosis 
demography 
75 new agents 
261 
disease_progression 
H-positive risk:  740 679 73 1110 417 96 1024 421 165 60 163 52 
H-negative risk:  679 740 1024 1110 421 417 96 73 163 165 52 60 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 89 28 

clinical_engagement 
diagnosis 
demography 
80 new agents 
262 
disease_progression 
H-positive risk:  744 689 70 1097 420 90 1028 428 162 59 161 52 
H-negative risk:  689 744 1028 1097 428 420 90 70 161 162 52 59 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 89 28 

clinical_engagement 
diagnosis 
demography 
72 new agents 
263 
disease_progression 
H-positive risk:  743 693 69 1093 424 91 1027 427 160 59 162 52 
H-negative risk:  693 743 1027 1093 427 424 91 69 162 160 52 59 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 90 27 

clinical_engagement 
diagnosis 
demography 
79 new agents 
264 
disease_progression 
H-positive risk:  739 697 70 1087 426 92 1026 430 158 60 161 54 
H-negative risk:  697 739 1026 1087 430 426 92 70 161 158 54 60 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 88 27 

clinical_engagement 
diagnosis 
demography 
90 new agents 
265 
disease_progression 
H-positive risk:  747 697 72 1090 421 92 1026 427 156 58 159 55 
H-negative risk:  697 747 1026 1090 427 421 92 72 159 156 55 58 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 89 26 

clinical_engagement 
diagnosis 
demography 
77 new agents 
266 
disease_progression 
H-positive risk:  740 699 70 1094 419 90 1032 423 158 60 159 56 
H-negative risk:  699 740 1032 1094 423 419 90 70 159 158 56 60 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 93 25 

clinical_engagement 
diagnosis 
demography 
82 new agents 
267 
disease_progression 
H-positive risk:  745 703 71 1093 414 88 1023 431 154 63 159 56 
H-negative risk:  703 745 1023 1093 431 414 88 71 159 154 56 63 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 94 25 

clinical_engagement 
diagnosis 
demography 
57 new agents 
268 
disease_progression 
H-positive risk:  750 700 74 1083 423 86 1016 437 153 63 161 54 
H-negative risk:  700 750 1016 1083 437 423 86 74 161 153 54 63 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 95 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
269 
disease_progression 
H-positive risk:  741 696 75 1079 429 90 1020 433 153 65 161 58 
H-negative risk:  696 741 1020 1079 433 429 90 75 161 153 58 65 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 94 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
270 
disease_progression 
H-positive risk:  731 697 73 1088 430 87 1028 426 153 65 165 57 
H-negative risk:  697 731 1028 1088 426 430 87 73 165 153 57 65 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 95 23 

clinical_engagement 
diagnosis 
demography 
82 new agents 
271 
disease_progression 
H-positive risk:  727 699 74 1087 429 87 1037 418 157 65 166 54 
H-negative risk:  699 727 1037 1087 418 429 87 74 166 157 54 65 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 94 23 

clinical_engagement 
diagnosis 
demography 
73 new agents 
272 
disease_progression 
H-positive risk:  730 701 72 1085 428 83 1036 420 161 60 168 56 
H-negative risk:  701 730 1036 1085 420 428 83 72 168 161 56 60 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 96 23 

clinical_engagement 
diagnosis 
demography 
92 new agents 
273 
disease_progression 
H-positive risk:  730 708 69 1101 418 80 1037 409 163 57 173 55 
H-negative risk:  708 730 1037 1101 409 418 80 69 173 163 55 57 
New BC onsets:  121
BC status:  4879 121 
BC subtype:  4879 97 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
274 
disease_progression 
H-positive risk:  727 700 70 1108 421 83 1038 406 163 58 170 56 
H-negative risk:  700 727 1038 1108 406 421 83 70 170 163 56 58 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 94 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
275 
disease_progression 
H-positive risk:  715 703 72 1103 425 83 1044 403 167 57 171 57 
H-negative risk:  703 715 1044 1103 403 425 83 72 171 167 57 57 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 91 23 

clinical_engagement 
diagnosis 
demography 
66 new agents 
276 
disease_progression 
H-positive risk:  709 691 70 1106 425 84 1050 410 167 58 173 57 
H-negative risk:  691 709 1050 1106 410 425 84 70 173 167 57 58 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 90 23 

clinical_engagement 
diagnosis 
demography 
85 new agents 
277 
disease_progression 
H-positive risk:  712 695 69 1108 420 84 1048 413 164 59 173 55 
H-negative risk:  695 712 1048 1108 413 420 84 69 173 164 55 59 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 93 23 

clinical_engagement 
diagnosis 
demography 
92 new agents 
278 
disease_progression 
H-positive risk:  716 700 71 1110 420 85 1036 414 159 65 174 50 
H-negative risk:  700 716 1036 1110 414 420 85 71 174 159 50 65 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 92 22 

clinical_engagement 
diagnosis 
demography 
81 new agents 
279 
disease_progression 
H-positive risk:  710 697 70 1112 428 86 1045 413 155 64 173 47 
H-negative risk:  697 710 1045 1112 413 428 86 70 173 155 47 64 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 91 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
280 
disease_progression 
H-positive risk:  710 693 69 1109 425 87 1051 416 154 64 174 48 
H-negative risk:  693 710 1051 1109 416 425 87 69 174 154 48 64 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 94 22 

clinical_engagement 
diagnosis 
demography 
71 new agents 
281 
disease_progression 
H-positive risk:  716 689 69 1112 425 85 1047 410 156 68 176 47 
H-negative risk:  689 716 1047 1112 410 425 85 69 176 156 47 68 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 94 21 

clinical_engagement 
diagnosis 
demography 
59 new agents 
282 
disease_progression 
H-positive risk:  713 688 70 1121 423 85 1044 409 156 68 177 46 
H-negative risk:  688 713 1044 1121 409 423 85 70 177 156 46 68 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 94 20 

clinical_engagement 
diagnosis 
demography 
71 new agents 
283 
disease_progression 
H-positive risk:  717 685 70 1123 423 85 1045 405 156 71 174 46 
H-negative risk:  685 717 1045 1123 405 423 85 70 174 156 46 71 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 94 21 

clinical_engagement 
diagnosis 
demography 
76 new agents 
284 
disease_progression 
H-positive risk:  716 688 73 1113 421 87 1055 400 156 71 171 49 
H-negative risk:  688 716 1055 1113 400 421 87 73 171 156 49 71 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 93 21 

clinical_engagement 
diagnosis 
demography 
63 new agents 
285 
disease_progression 
H-positive risk:  716 690 73 1108 423 83 1064 390 160 72 173 48 
H-negative risk:  690 716 1064 1108 390 423 83 73 173 160 48 72 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 91 20 

clinical_engagement 
diagnosis 
demography 
59 new agents 
286 
disease_progression 
H-positive risk:  724 693 73 1101 420 84 1065 390 157 73 172 48 
H-negative risk:  693 724 1065 1101 390 420 84 73 172 157 48 73 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 92 18 

clinical_engagement 
diagnosis 
demography 
82 new agents 
287 
disease_progression 
H-positive risk:  733 691 70 1094 425 84 1062 399 156 68 172 46 
H-negative risk:  691 733 1062 1094 399 425 84 70 172 156 46 68 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 94 18 

clinical_engagement 
diagnosis 
demography 
80 new agents 
288 
disease_progression 
H-positive risk:  737 695 71 1083 428 81 1069 393 157 69 171 46 
H-negative risk:  695 737 1069 1083 393 428 81 71 171 157 46 69 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 96 16 

clinical_engagement 
diagnosis 
demography 
63 new agents 
289 
disease_progression 
H-positive risk:  734 693 71 1084 424 82 1067 396 159 71 171 48 
H-negative risk:  693 734 1067 1084 396 424 82 71 171 159 48 71 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 96 16 

clinical_engagement 
diagnosis 
demography 
74 new agents 
290 
disease_progression 
H-positive risk:  735 696 71 1089 419 83 1070 392 160 70 169 46 
H-negative risk:  696 735 1070 1089 392 419 83 71 169 160 46 70 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 96 16 

clinical_engagement 
diagnosis 
demography 
74 new agents 
291 
disease_progression 
H-positive risk:  732 685 70 1092 415 84 1077 395 162 68 171 49 
H-negative risk:  685 732 1077 1092 395 415 84 70 171 162 49 68 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 95 17 

clinical_engagement 
diagnosis 
demography 
72 new agents 
292 
disease_progression 
H-positive risk:  729 683 71 1089 415 83 1076 401 162 70 171 50 
H-negative risk:  683 729 1076 1089 401 415 83 71 171 162 50 70 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 94 16 

clinical_engagement 
diagnosis 
demography 
75 new agents 
293 
disease_progression 
H-positive risk:  727 686 71 1091 412 82 1081 400 158 69 168 55 
H-negative risk:  686 727 1081 1091 400 412 82 71 168 158 55 69 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 93 20 

clinical_engagement 
diagnosis 
demography 
83 new agents 
294 
disease_progression 
H-positive risk:  719 690 74 1083 411 79 1091 409 156 66 167 55 
H-negative risk:  690 719 1091 1083 409 411 79 74 167 156 55 66 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 91 20 

clinical_engagement 
diagnosis 
demography 
66 new agents 
295 
disease_progression 
H-positive risk:  718 685 74 1085 418 75 1092 403 159 68 167 56 
H-negative risk:  685 718 1092 1085 403 418 75 74 167 159 56 68 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 93 20 

clinical_engagement 
diagnosis 
demography 
69 new agents 
296 
disease_progression 
H-positive risk:  709 693 74 1076 418 74 1102 401 161 67 170 55 
H-negative risk:  693 709 1102 1076 401 418 74 74 170 161 55 67 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 94 19 

clinical_engagement 
diagnosis 
demography 
74 new agents 
297 
disease_progression 
H-positive risk:  703 696 73 1071 420 75 1113 396 159 65 173 56 
H-negative risk:  696 703 1113 1071 396 420 75 73 173 159 56 65 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 93 20 

clinical_engagement 
diagnosis 
demography 
69 new agents 
298 
disease_progression 
H-positive risk:  710 691 73 1065 424 78 1109 402 156 65 171 56 
H-negative risk:  691 710 1109 1065 402 424 78 73 171 156 56 65 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 93 20 

clinical_engagement 
diagnosis 
demography 
92 new agents 
299 
disease_progression 
H-positive risk:  709 696 76 1062 428 81 1109 397 152 65 170 55 
H-negative risk:  696 709 1109 1062 397 428 81 76 170 152 55 65 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 91 21 

clinical_engagement 
diagnosis 
demography 
78 new agents 
300 
disease_progression 
H-positive risk:  707 700 76 1065 423 80 1110 396 157 62 170 54 
H-negative risk:  700 707 1110 1065 396 423 80 76 170 157 54 62 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 92 21 

clinical_engagement 
diagnosis 
demography 
77 new agents 
301 
disease_progression 
H-positive risk:  704 701 78 1061 423 78 1123 390 156 64 166 56 
H-negative risk:  701 704 1123 1061 390 423 78 78 166 156 56 64 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 91 22 

clinical_engagement 
diagnosis 
demography 
83 new agents 
302 
disease_progression 
H-positive risk:  710 707 79 1061 422 79 1118 384 153 66 165 56 
H-negative risk:  707 710 1118 1061 384 422 79 79 165 153 56 66 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 90 21 

clinical_engagement 
diagnosis 
demography 
69 new agents 
303 
disease_progression 
H-positive risk:  705 701 79 1068 427 80 1116 386 152 61 168 57 
H-negative risk:  701 705 1116 1068 386 427 80 79 168 152 57 61 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 91 20 

clinical_engagement 
diagnosis 
demography 
66 new agents 
304 
disease_progression 
H-positive risk:  697 696 78 1078 426 80 1125 380 154 59 170 57 
H-negative risk:  696 697 1125 1078 380 426 80 78 170 154 57 59 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 91 20 

clinical_engagement 
diagnosis 
demography 
77 new agents 
305 
disease_progression 
H-positive risk:  693 699 79 1066 429 80 1125 383 156 61 173 56 
H-negative risk:  699 693 1125 1066 383 429 80 79 173 156 56 61 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 93 20 

clinical_engagement 
diagnosis 
demography 
63 new agents 
306 
disease_progression 
H-positive risk:  697 695 77 1068 424 81 1132 385 154 58 172 57 
H-negative risk:  695 697 1132 1068 385 424 81 77 172 154 57 58 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 91 20 

clinical_engagement 
diagnosis 
demography 
76 new agents 
307 
disease_progression 
H-positive risk:  699 691 78 1080 430 83 1119 381 153 57 172 57 
H-negative risk:  691 699 1119 1080 381 430 83 78 172 153 57 57 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 92 20 

clinical_engagement 
diagnosis 
demography 
84 new agents 
308 
disease_progression 
H-positive risk:  693 697 79 1075 429 84 1121 384 150 60 172 56 
H-negative risk:  697 693 1121 1075 384 429 84 79 172 150 56 60 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 90 22 

clinical_engagement 
diagnosis 
demography 
77 new agents 
309 
disease_progression 
H-positive risk:  694 698 80 1077 424 83 1120 384 150 62 172 56 
H-negative risk:  698 694 1120 1077 384 424 83 80 172 150 56 62 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 89 22 

clinical_engagement 
diagnosis 
demography 
97 new agents 
310 
disease_progression 
H-positive risk:  687 699 84 1069 432 81 1121 382 151 64 170 60 
H-negative risk:  699 687 1121 1069 382 432 81 84 170 151 60 64 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 89 24 

clinical_engagement 
diagnosis 
demography 
64 new agents 
311 
disease_progression 
H-positive risk:  683 695 89 1067 430 81 1121 390 150 63 170 61 
H-negative risk:  695 683 1121 1067 390 430 81 89 170 150 61 63 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 88 24 

clinical_engagement 
diagnosis 
demography 
78 new agents 
312 
disease_progression 
H-positive risk:  683 690 91 1071 434 82 1119 386 150 61 171 62 
H-negative risk:  690 683 1119 1071 386 434 82 91 171 150 62 61 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 88 24 

clinical_engagement 
diagnosis 
demography 
80 new agents 
313 
disease_progression 
H-positive risk:  680 690 93 1066 431 80 1123 390 150 59 176 62 
H-negative risk:  690 680 1123 1066 390 431 80 93 176 150 62 59 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 89 23 

clinical_engagement 
diagnosis 
demography 
69 new agents 
314 
disease_progression 
H-positive risk:  676 697 94 1064 428 80 1132 386 152 58 176 57 
H-negative risk:  697 676 1132 1064 386 428 80 94 176 152 57 58 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 91 23 

clinical_engagement 
diagnosis 
demography 
97 new agents 
315 
disease_progression 
H-positive risk:  674 704 94 1071 426 77 1132 381 150 61 173 57 
H-negative risk:  704 674 1132 1071 381 426 77 94 173 150 57 61 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 92 25 

clinical_engagement 
diagnosis 
demography 
80 new agents 
316 
disease_progression 
H-positive risk:  673 705 96 1073 439 77 1126 372 150 59 174 56 
H-negative risk:  705 673 1126 1073 372 439 77 96 174 150 56 59 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 91 24 

clinical_engagement 
diagnosis 
demography 
77 new agents 
317 
disease_progression 
H-positive risk:  666 702 98 1068 441 79 1136 371 150 58 172 59 
H-negative risk:  702 666 1136 1068 371 441 79 98 172 150 59 58 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 93 24 

clinical_engagement 
diagnosis 
demography 
60 new agents 
318 
disease_progression 
H-positive risk:  666 699 100 1073 435 80 1134 373 152 56 171 61 
H-negative risk:  699 666 1134 1073 373 435 80 100 171 152 61 56 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 94 24 

clinical_engagement 
diagnosis 
demography 
98 new agents 
319 
disease_progression 
H-positive risk:  660 709 100 1063 431 79 1145 368 153 54 176 62 
H-negative risk:  709 660 1145 1063 368 431 79 100 176 153 62 54 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 93 24 

clinical_engagement 
diagnosis 
demography 
88 new agents 
320 
disease_progression 
H-positive risk:  657 717 101 1076 424 84 1134 371 153 50 174 59 
H-negative risk:  717 657 1134 1076 371 424 84 101 174 153 59 50 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 89 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
321 
disease_progression 
H-positive risk:  654 718 102 1073 428 85 1137 371 151 49 171 61 
H-negative risk:  718 654 1137 1073 371 428 85 102 171 151 61 49 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 92 25 

clinical_engagement 
diagnosis 
demography 
71 new agents 
322 
disease_progression 
H-positive risk:  659 724 104 1068 430 85 1133 369 147 50 172 59 
H-negative risk:  724 659 1133 1068 369 430 85 104 172 147 59 50 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 92 24 

clinical_engagement 
diagnosis 
demography 
87 new agents 
323 
disease_progression 
H-positive risk:  662 723 105 1053 437 83 1133 373 146 51 174 60 
H-negative risk:  723 662 1133 1053 373 437 83 105 174 146 60 51 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 91 24 

clinical_engagement 
diagnosis 
demography 
83 new agents 
324 
disease_progression 
H-positive risk:  669 722 103 1051 439 83 1122 378 146 51 176 60 
H-negative risk:  722 669 1122 1051 378 439 83 103 176 146 60 51 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 86 23 

clinical_engagement 
diagnosis 
demography 
78 new agents 
325 
disease_progression 
H-positive risk:  670 726 101 1054 440 83 1111 383 143 53 177 59 
H-negative risk:  726 670 1111 1054 383 440 83 101 177 143 59 53 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 86 20 

clinical_engagement 
diagnosis 
demography 
68 new agents 
326 
disease_progression 
H-positive risk:  666 733 103 1045 445 83 1108 387 141 54 175 60 
H-negative risk:  733 666 1108 1045 387 445 83 103 175 141 60 54 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 86 21 

clinical_engagement 
diagnosis 
demography 
78 new agents 
327 
disease_progression 
H-positive risk:  667 738 101 1039 443 84 1102 397 137 57 176 59 
H-negative risk:  738 667 1102 1039 397 443 84 101 176 137 59 57 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 86 21 

clinical_engagement 
diagnosis 
demography 
94 new agents 
328 
disease_progression 
H-positive risk:  670 743 103 1034 440 89 1101 398 135 55 174 58 
H-negative risk:  743 670 1101 1034 398 440 89 103 174 135 58 55 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
81 new agents 
329 
disease_progression 
H-positive risk:  669 740 102 1039 438 91 1096 402 138 54 173 58 
H-negative risk:  740 669 1096 1039 402 438 91 102 173 138 58 54 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 77 22 

clinical_engagement 
diagnosis 
demography 
74 new agents 
330 
disease_progression 
H-positive risk:  672 727 100 1034 442 90 1101 404 140 55 176 59 
H-negative risk:  727 672 1101 1034 404 442 90 100 176 140 59 55 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 75 22 

clinical_engagement 
diagnosis 
demography 
66 new agents 
331 
disease_progression 
H-positive risk:  667 728 101 1035 437 91 1104 407 139 54 176 61 
H-negative risk:  728 667 1104 1035 407 437 91 101 176 139 61 54 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
69 new agents 
332 
disease_progression 
H-positive risk:  669 714 103 1045 435 91 1102 405 140 53 179 64 
H-negative risk:  714 669 1102 1045 405 435 91 103 179 140 64 53 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 75 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
333 
disease_progression 
H-positive risk:  670 719 104 1037 433 89 1106 407 142 51 178 64 
H-negative risk:  719 670 1106 1037 407 433 89 104 178 142 64 51 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 77 21 

clinical_engagement 
diagnosis 
demography 
69 new agents 
334 
disease_progression 
H-positive risk:  670 714 106 1035 436 92 1103 411 142 50 178 63 
H-negative risk:  714 670 1103 1035 411 436 92 106 178 142 63 50 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 75 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
335 
disease_progression 
H-positive risk:  671 712 105 1040 435 89 1103 413 145 50 174 63 
H-negative risk:  712 671 1103 1040 413 435 89 105 174 145 63 50 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 75 23 

clinical_engagement 
diagnosis 
demography 
67 new agents 
336 
disease_progression 
H-positive risk:  672 714 103 1039 435 92 1102 410 142 52 175 64 
H-negative risk:  714 672 1102 1039 410 435 92 103 175 142 64 52 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 74 24 

clinical_engagement 
diagnosis 
demography 
88 new agents 
337 
disease_progression 
H-positive risk:  675 711 101 1042 433 91 1098 412 142 53 174 68 
H-negative risk:  711 675 1098 1042 412 433 91 101 174 142 68 53 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 75 23 

clinical_engagement 
diagnosis 
demography 
88 new agents 
338 
disease_progression 
H-positive risk:  670 704 103 1049 425 90 1098 426 141 52 172 70 
H-negative risk:  704 670 1098 1049 426 425 90 103 172 141 70 52 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 74 23 

clinical_engagement 
diagnosis 
demography 
70 new agents 
339 
disease_progression 
H-positive risk:  669 700 101 1045 440 89 1095 422 141 53 173 72 
H-negative risk:  700 669 1095 1045 422 440 89 101 173 141 72 53 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 71 23 

clinical_engagement 
diagnosis 
demography 
79 new agents 
340 
disease_progression 
H-positive risk:  666 695 100 1046 456 88 1088 422 142 51 175 71 
H-negative risk:  695 666 1088 1046 422 456 88 100 175 142 71 51 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 72 23 

clinical_engagement 
diagnosis 
demography 
56 new agents 
341 
disease_progression 
H-positive risk:  667 689 99 1054 451 85 1088 421 144 52 180 70 
H-negative risk:  689 667 1088 1054 421 451 85 99 180 144 70 52 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 77 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
342 
disease_progression 
H-positive risk:  675 683 98 1062 451 84 1078 419 147 53 178 72 
H-negative risk:  683 675 1078 1062 419 451 84 98 178 147 72 53 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
74 new agents 
343 
disease_progression 
H-positive risk:  676 686 96 1064 454 85 1076 416 145 53 177 72 
H-negative risk:  686 676 1076 1064 416 454 85 96 177 145 72 53 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 74 26 

clinical_engagement 
diagnosis 
demography 
81 new agents 
344 
disease_progression 
H-positive risk:  676 686 99 1064 450 86 1074 418 147 54 175 71 
H-negative risk:  686 676 1074 1064 418 450 86 99 175 147 71 54 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 71 28 

clinical_engagement 
diagnosis 
demography 
82 new agents 
345 
disease_progression 
H-positive risk:  676 687 98 1064 447 84 1088 421 149 52 165 69 
H-negative risk:  687 676 1088 1064 421 447 84 98 165 149 69 52 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 71 28 

clinical_engagement 
diagnosis 
demography 
83 new agents 
346 
disease_progression 
H-positive risk:  679 693 95 1067 443 81 1092 409 151 55 167 68 
H-negative risk:  693 679 1092 1067 409 443 81 95 167 151 68 55 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 75 28 

clinical_engagement 
diagnosis 
demography 
82 new agents 
347 
disease_progression 
H-positive risk:  681 692 95 1063 454 81 1089 406 154 55 163 67 
H-negative risk:  692 681 1089 1063 406 454 81 95 163 154 67 55 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
83 new agents 
348 
disease_progression 
H-positive risk:  683 693 95 1057 455 82 1093 406 152 55 161 68 
H-negative risk:  693 683 1093 1057 406 455 82 95 161 152 68 55 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
90 new agents 
349 
disease_progression 
H-positive risk:  681 702 96 1053 455 86 1100 394 154 55 157 67 
H-negative risk:  702 681 1100 1053 394 455 86 96 157 154 67 55 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 78 25 

clinical_engagement 
diagnosis 
demography 
86 new agents 
350 
disease_progression 
H-positive risk:  685 708 97 1052 447 88 1104 389 154 54 155 67 
H-negative risk:  708 685 1104 1052 389 447 88 97 155 154 67 54 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
351 
disease_progression 
H-positive risk:  687 710 95 1056 450 87 1092 391 156 51 158 67 
H-negative risk:  710 687 1092 1056 391 450 87 95 158 156 67 51 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 79 24 

clinical_engagement 
diagnosis 
demography 
85 new agents 
352 
disease_progression 
H-positive risk:  676 707 96 1056 457 88 1099 388 157 51 156 69 
H-negative risk:  707 676 1099 1056 388 457 88 96 156 157 69 51 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
83 new agents 
353 
disease_progression 
H-positive risk:  678 705 95 1066 450 88 1103 387 157 51 154 66 
H-negative risk:  705 678 1103 1066 387 450 88 95 154 157 66 51 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 77 21 

clinical_engagement 
diagnosis 
demography 
80 new agents 
354 
disease_progression 
H-positive risk:  686 708 96 1065 446 89 1097 387 158 51 152 65 
H-negative risk:  708 686 1097 1065 387 446 89 96 152 158 65 51 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 80 21 

clinical_engagement 
diagnosis 
demography 
79 new agents 
355 
disease_progression 
H-positive risk:  691 709 97 1066 437 88 1097 390 160 51 150 64 
H-negative risk:  709 691 1097 1066 390 437 88 97 150 160 64 51 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 81 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
356 
disease_progression 
H-positive risk:  692 716 99 1055 439 89 1098 390 163 49 149 61 
H-negative risk:  716 692 1098 1055 390 439 89 99 149 163 61 49 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 85 18 

clinical_engagement 
diagnosis 
demography 
66 new agents 
357 
disease_progression 
H-positive risk:  688 712 96 1043 454 91 1100 392 163 51 149 61 
H-negative risk:  712 688 1100 1043 392 454 91 96 149 163 61 51 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 86 18 

clinical_engagement 
diagnosis 
demography 
68 new agents 
358 
disease_progression 
H-positive risk:  686 703 94 1048 449 95 1101 401 159 53 148 63 
H-negative risk:  703 686 1101 1048 401 449 95 94 148 159 63 53 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 86 18 

clinical_engagement 
diagnosis 
demography 
72 new agents 
359 
disease_progression 
H-positive risk:  684 696 91 1060 448 94 1097 405 159 56 148 62 
H-negative risk:  696 684 1097 1060 405 448 94 91 148 159 62 56 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 86 18 

clinical_engagement 
diagnosis 
demography 
84 new agents 
360 
disease_progression 
H-positive risk:  681 697 92 1059 446 92 1102 407 155 55 150 64 
H-negative risk:  697 681 1102 1059 407 446 92 92 150 155 64 55 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 86 17 

clinical_engagement 
diagnosis 
demography 
66 new agents 
Time difference of 17.44429 mins
This is task 24
date
